Selin Yaman Seval/LinkedIn
Sep 25, 2026, 19:45
Selin Yaman Seval: ITP Is More Than a Low Platelet Count
Selin Yaman Seval, Marketing Lead, New Launches (Rare Blood Disorders and Hemaophilia) at Sanofi, shared a post on LinkedIn:
“ITP is more than a low platelet count — it’s a complex immune dysregulation that can impact patients’ daily lives in many ways.
Proud to stand with the ITP community, raise awareness, and keep patients at the heart of the conversation.”
Stay updated with Hemostasis Today.
-
Sep 25, 2026, 19:47Bryan Cotton: DOACs Versus Nothing When Stroke Risk Is Not Zero
-
Sep 25, 2026, 19:44Cy R. Wilkins: Treating Chemotherapy-Induced Thrombocytopenia Beyond the Platelet Count
-
Sep 25, 2026, 19:42Mahitap Hossam: What the Platelet Count Cannot Show in ITP
-
Sep 25, 2026, 17:13Sam Tsimikas: Lp(a) and Oxidized Phospholipids Link Lipoprotein Biology to Platelet Activation
-
Sep 25, 2026, 16:56Cindy Neunert: The Future of Personalized ITP Care
-
Sep 25, 2026, 16:26Gemma Postil: AI Tools in Modern Health Research
-
Sep 25, 2026, 16:01Mostafa Hammam: When aPTT Correction Is Not the End
-
Sep 25, 2026, 15:50Adam Boruchov: Registration Is Open For The 2026 New England Hematologic Diseases Symposium
-
Sep 25, 2026, 15:23Bringing Hope and Treatment Access to Morocco’s Hemophilia Community – World Federation of Hemophilia